Correlation Between Alzamend Neuro and Sigilon Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Alzamend Neuro and Sigilon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alzamend Neuro and Sigilon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alzamend Neuro and Sigilon Therapeutics, you can compare the effects of market volatilities on Alzamend Neuro and Sigilon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alzamend Neuro with a short position of Sigilon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alzamend Neuro and Sigilon Therapeutics.

Diversification Opportunities for Alzamend Neuro and Sigilon Therapeutics

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between Alzamend and Sigilon is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Alzamend Neuro and Sigilon Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sigilon Therapeutics and Alzamend Neuro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alzamend Neuro are associated (or correlated) with Sigilon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sigilon Therapeutics has no effect on the direction of Alzamend Neuro i.e., Alzamend Neuro and Sigilon Therapeutics go up and down completely randomly.

Pair Corralation between Alzamend Neuro and Sigilon Therapeutics

If you would invest  2,111  in Sigilon Therapeutics on August 29, 2024 and sell it today you would earn a total of  0.00  from holding Sigilon Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy2.33%
ValuesDaily Returns

Alzamend Neuro  vs.  Sigilon Therapeutics

 Performance 
       Timeline  
Alzamend Neuro 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Alzamend Neuro has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Sigilon Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sigilon Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Sigilon Therapeutics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Alzamend Neuro and Sigilon Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Alzamend Neuro and Sigilon Therapeutics

The main advantage of trading using opposite Alzamend Neuro and Sigilon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alzamend Neuro position performs unexpectedly, Sigilon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sigilon Therapeutics will offset losses from the drop in Sigilon Therapeutics' long position.
The idea behind Alzamend Neuro and Sigilon Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon